Showing results (11-20 of 125) with videos related to
Sort By:
Pageof 13
Journal of Pharmacological and Toxicological Methods|December 6, 2014
Increasing the flexibility of the LANCE cAMP detection kitMorag Rose Hunter, Michelle GlassAdvances in Pharmacology (San Diego, Calif.)|August 23, 2017
Functional Selectivity at Cannabinoid ReceptorsRichard Priestley, Michelle Glass, David KendallProstaglandins, Leukotrienes, and Essential Fatty Acids|December 20, 2003
Cannabis, cannabinoids and reproductionBoram Park, John M McPartland, Michelle GlassCellular Signalling|December 1, 2020
Biased agonism at the cannabinoid receptors - Evidence from synthetic cannabinoid receptor agonistsMonica Patel, David B Finlay, Michelle GlassCannabis and Cannabinoid Research|September 2, 2017
Cannabinoid CB1 and CB2 Receptor Signaling and BiasMikkel Søes Ibsen, Mark Connor, Michelle GlassBritish Journal of Pharmacology|July 2, 2010
The endocannabinoid system as a target for the treatment of neurodegenerative diseaseEmma L Scotter, Mary E Abood, Michelle GlassCPT: Pharmacometrics & Systems Pharmacology|April 23, 2025
Development of a Heuristic Machine Analogy Method for Model Simplification With an Application to a Large-Scale Model of Gi/Gs SignalingLiang Yang, David Finlay, Michelle Glass, et al.Frontiers in Bioscience (Landmark Edition)|March 11, 2009
Cannabinoid Receptors: A brief history and what notEuan Scott Graham, John Clive Ashton, Michelle GlassAdvances in Pharmacology (San Diego, Calif.)|August 23, 2017
Is the Cannabinoid CB2 Receptor a Major Regulator of the Neuroinflammatory Axis of the Neurovascular Unit in Humans?Dan T Kho, Michelle Glass, Euan S GrahamEuropean Journal of Pharmacology|July 25, 2024
The impact of piperazine and antipsychotic co-exposures and CB1 blockade on the effects elicited by AMB-FUBINACA, a synthetic cannabinoid, in miceLucy R Thomsen, Michelle Glass, Rhonda J RosengrenPageof 13